Company Filing History:
Years Active: 2014-2020
Title: Innovator Spotlight: Hanna Rapaport
Introduction
Hanna Rapaport is a prominent inventor based in Lehavim, Israel, known for her impactful contributions to the field of drug delivery and biomedicine. With a total of six patents to her name, Rapaport’s work reflects a deep commitment to advancing medical technologies that benefit patient care.
Latest Patents
Among her latest inventions, Rapaport has developed innovative peptide-polypeptide co-assembled nanoparticles for drug delivery. These nanoparticles include at least one polypeptide, which is a polyanion, and an amphiphilic peptide capable of forming a β-sheet structure. This invention showcases her expertise in creating pharmaceutical compositions that effectively deliver active ingredients through advanced nanoparticle technology.
Another groundbreaking patent includes functionalized titanium binding peptides and implants coated with these peptides. This isolated peptide comprises a titanium oxide binding amino acid sequence connected via a beta sheet breaker linker, enhancing the functionality of titanium devices in medical applications.
Career Highlights
Hanna Rapaport works with the Ben-Gurion University of the Negev Research and Development Authority, where she continues to innovate and push the boundaries of research in her field. Her work has resulted in significant advancements, particularly in the areas of drug delivery systems and bio-implant applications.
Collaborations
Throughout her career, Rapaport has collaborated with talented individuals such as Anna Gittelman and Ifat Cohen, further enriching the collective research efforts and enhancing the scope of their innovations. These collaborations highlight the importance of teamwork in achieving breakthroughs in science and technology.
Conclusion
Hanna Rapaport’s contributions to the field of biomedicine and her inventive spirit exemplify the power of innovation in enhancing healthcare solutions. With a growing portfolio of patents, her work continues to inspire future generations of inventors and researchers in the quest to improve therapeutic strategies.